Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.500
+0.260 (11.61%)
At close: Nov 24, 2025, 4:00 PM EST
2.490
-0.010 (-0.40%)
After-hours: Nov 24, 2025, 7:59 PM EST

Iovance Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-397.63-372.18-444.04-395.89-342.25-259.58
Upgrade
Depreciation & Amortization
47.3843.6133.1321.1413.988.71
Upgrade
Loss (Gain) From Sale of Assets
-5.52-5.57----
Upgrade
Asset Writedown & Restructuring Costs
7.367.36-0.4--
Upgrade
Loss (Gain) From Sale of Investments
-8.63-10.26-3.610.476.011.87
Upgrade
Stock-Based Compensation
80.74109.6362.6384.0269.7740.89
Upgrade
Other Operating Activities
9.15-3-3.41---
Upgrade
Change in Accounts Receivable
-10.99-69.19-0.15---
Upgrade
Change in Inventory
-24.67-39.92-10.12---
Upgrade
Change in Accounts Payable
-7.52-7.844.835.886.98-2.96
Upgrade
Change in Other Net Operating Assets
-12.78-5.61-1.08-8.7817.585.95
Upgrade
Operating Cash Flow
-323.14-352.98-361.82-292.76-227.94-205.13
Upgrade
Capital Expenditures
-28.68-11.07-22.29-20.43-37.57-46.79
Upgrade
Cash Acquisitions
--52.57-212.63---
Upgrade
Investment in Securities
99.08-32.7779.68276.8837.71-271.06
Upgrade
Investing Cash Flow
70.4-96.41-155.24256.460.13-317.85
Upgrade
Long-Term Debt Issued
----1-
Upgrade
Net Debt Issued (Repaid)
----1-
Upgrade
Issuance of Common Stock
254.4403.52465.75192.8238.27576.71
Upgrade
Repurchase of Common Stock
-7.49-12.86-2.8-2.65--0.28
Upgrade
Financing Cash Flow
246.91390.66462.96190.15239.27576.42
Upgrade
Foreign Exchange Rate Adjustments
-0.61-0.54-2.74---
Upgrade
Net Cash Flow
-6.44-59.27-56.84153.8511.4653.44
Upgrade
Free Cash Flow
-351.82-364.05-384.11-313.18-265.52-251.93
Upgrade
Free Cash Flow Margin
-140.49%-221.89%-32305.30%---
Upgrade
Free Cash Flow Per Share
-1.06-1.26-1.63-1.97-1.73-1.82
Upgrade
Levered Free Cash Flow
-172.85-203.22-211.47-173.54-129.35-141.4
Upgrade
Unlevered Free Cash Flow
-172.85-203.22-211.47-173.54-129.35-141.4
Upgrade
Change in Working Capital
-55.96-122.56-6.52-2.8924.552.98
Upgrade
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q